459 related articles for article (PubMed ID: 30223117)
1. Discovery of novel human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
Eur J Med Chem; 2018 Oct; 158():286-301. PubMed ID: 30223117
[TBL] [Abstract][Full Text] [Related]
2. Newer human inosine 5'-monophosphate dehydrogenase 2 (hIMPDH2) inhibitors as potential anticancer agents.
Shah CP; Kharkar PS
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):972-977. PubMed ID: 29792360
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors.
Sahu NU; Purushothaman G; Thiruvenkatam V; Kharkar PS
Drug Dev Res; 2019 Feb; 80(1):125-132. PubMed ID: 30381846
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and biological evaluation of Helicobacter pylori inosine 5'-monophosphate dehydrogenase (HpIMPDH) inhibitors. Further optimization of selectivity towards HpIMPDH over human IMPDH2.
Shah CP; Purushothaman G; Thiruvenkatam V; Kirubakaran S; Juvale K; Kharkar PS
Bioorg Chem; 2019 Jun; 87():753-764. PubMed ID: 30974298
[TBL] [Abstract][Full Text] [Related]
5. Hit discovery of Mycobacterium tuberculosis inosine 5'-monophosphate dehydrogenase, GuaB2, inhibitors.
Sahu NU; Singh V; Ferraris DM; Rizzi M; Kharkar PS
Bioorg Med Chem Lett; 2018 Jun; 28(10):1714-1718. PubMed ID: 29699922
[TBL] [Abstract][Full Text] [Related]
6. Discovery of N-(2,3,5-triazoyl)mycophenolic amide and mycophenolic epoxyketone as novel inhibitors of human IMPDH.
Sunohara K; Mitsuhashi S; Shigetomi K; Ubukata M
Bioorg Med Chem Lett; 2013 Sep; 23(18):5140-4. PubMed ID: 23937979
[TBL] [Abstract][Full Text] [Related]
7. NAD-based inhibitors with anticancer potential.
Felczak K; Vince R; Pankiewicz KW
Bioorg Med Chem Lett; 2014 Jan; 24(1):332-6. PubMed ID: 24269162
[TBL] [Abstract][Full Text] [Related]
8. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
[TBL] [Abstract][Full Text] [Related]
10. [The determination and clinical application of inosine 5’-monophosphate dehydrogenase activity].
Liu FY; Qiu XY; Jiao Z
Yao Xue Xue Bao; 2016 Nov; 51(11):1666-73. PubMed ID: 29908108
[TBL] [Abstract][Full Text] [Related]
11. Development, synthesis, and biological evaluation of sulfonyl-α-l-amino acids as potential anti-Helicobacter pylori and IMPDH inhibitors.
Galal AMF; Mohamed HS; Abdel-Aziz MM; Hanna AG
Arch Pharm (Weinheim); 2021 Jun; 354(6):e2000385. PubMed ID: 33576040
[TBL] [Abstract][Full Text] [Related]
12. Inosine 5'-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents.
Fotie J
Mini Rev Med Chem; 2018; 18(8):656-671. PubMed ID: 27334467
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of human Molt-4 leukemia type II inosine 5'-monophosphate dehydrogenase by the 1,5-diazabicyclo[3.1.0]hexane-2,4-diones.
Barnes BJ; Eakin AE; Izydore RA; Hall IH
Biochemistry; 2000 Nov; 39(45):13641-50. PubMed ID: 11076502
[TBL] [Abstract][Full Text] [Related]
14. Repurposing existing drugs: identification of irreversible IMPDH inhibitors by high-throughput screening.
Sarwono AEY; Mitsuhashi S; Kabir MHB; Shigetomi K; Okada T; Ohsaka F; Otsuguro S; Maenaka K; Igarashi M; Kato K; Ubukata M
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):171-178. PubMed ID: 30451014
[TBL] [Abstract][Full Text] [Related]
15. Novel inhibitors of inosine monophosphate dehydrogenase in patent literature of the last decade.
Petrelli R; Vita P; Torquati I; Felczak K; Wilson DJ; Franchetti P; Cappellacci L
Recent Pat Anticancer Drug Discov; 2013 May; 8(2):103-25. PubMed ID: 23016672
[TBL] [Abstract][Full Text] [Related]
16. Inosine monophosphate dehydrogenase as a probe in antiviral drug discovery.
Nair V; Shu Q
Antivir Chem Chemother; 2007; 18(5):245-58. PubMed ID: 18046958
[TBL] [Abstract][Full Text] [Related]
17. A novel series of non-nucleoside inhibitors of inosine 5'-monophosphate dehydrogenase with immunosuppressive activity.
Franklin TJ; Morris WP; Jacobs VN; Culbert EJ; Heys CA; Ward WH; Cook PN; Jung F; Plé P
Biochem Pharmacol; 1999 Sep; 58(5):867-76. PubMed ID: 10449198
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of the inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Cholewiński G; Iwaszkiewicz-Grześ D; Prejs M; Głowacka A; Dzierzbicka K
J Enzyme Inhib Med Chem; 2015; 30(4):550-63. PubMed ID: 25198892
[TBL] [Abstract][Full Text] [Related]
19. Computational insights into the inhibition of inosine 5'-monophosphate dehydrogenase by mycophenolic acid analogs: three-dimensional quantitative structure-activity relationship and molecular docking studies.
Yang N; Wang J; Wang ZW; Wang QH; Yang HG; Wang XJ; Cheng MS
Chem Biol Drug Des; 2012 Jun; 79(6):1063-71. PubMed ID: 22405057
[TBL] [Abstract][Full Text] [Related]
20. 3-cyanoindole-based inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.
Dhar TG; Shen Z; Gu HH; Chen P; Norris D; Watterson SH; Ballentine SK; Fleener CA; Rouleau KA; Barrish JC; Townsend R; Hollenbaugh DL; Iwanowicz EJ
Bioorg Med Chem Lett; 2003 Oct; 13(20):3557-60. PubMed ID: 14505670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]